MarketInOut Stock Screener Log In | Sign Up

Lonza Group AG

SIX • Healthcare • Diagnostics & Research • Quote as of 10/29/2026 17:30
Lonza Group AG stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeSIX
Market Capitalization43,988 mln
Float69.40 mln
Earnings Date01/28/2027

EPS

15.09
Stretched

P / E

42.35
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.12
Reliable

1-Year Forecast

696.61
Modest upside

Relative Strength

94 / 100
Top performer

Business Description

Lonza Group AG is a Swiss company founded in 1897 and based in Basel, helping pharmaceutical and biotechnology companies develop and manufacture their products across markets worldwide. It provides a wide range of services covering biological medicines, chemical compounds, and advanced treatments such as cell and gene therapies. The company works with clients from early research stages through to full-scale production, supporting both the active ingredients and the final drug product.

Key Fundamentals

EPS15.09
P/E42.35
ROE-1.38
RPS98.33
ROIC8.55
ROA-0.61
Interest Cover13.18
EBITDA, mln1,997
EV / EBITDA22.31
EV / EBIT31.85
Revenue, mln6,329
EV / Revenue7.04

Quote Details

Last 640.80
Change 11 (1.75%)
Open 632.40
Volume 138,726
Turnover 88,895,616
Average Volume 134,479

Financial Ratios

Pre-Tax Profit Margin20
Leverage Ratio2.25
Current Ratio1.66
Price / Book4.93
Price / Tangible Book6.84
Price / Cash Flow30.48
Price / Free Cash Flow187
Debt / Equity0.51
Price / Sales6.36
PEG Ratio1.14

Financial Strength

Altman Z-Score3.9
Piotroski F-Score 6 / 9
Beneish M-Score-3.12
Price to Intrinsic Value8.21
1-Year Target Price696.61
Shiller PE Ratio47.86

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.01% 78 / 100   
1 Month 11.4% 97 / 100   
2 Months 14.55% 89 / 100   
6 Months 35.14% 95 / 100   
1 Year 11.92% 47 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog